TRLV earnings: next report 2026-08-06, real EPS beat/miss history, P/E -20.64. Updated 2026-07-23.
Trulieve Cannabis (TRLV) Research Hub
Trulieve Cannabis (TRLV) trades on NYSE, US in the Healthcare (Medical - Pharmaceuticals) sector. As of 2026-09-11, shares last closed at 11.31 USD (-3.91%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -20.64, market cap 1.50B. This hub links to the full technical, earnings and options research available for TRLV.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Pharmaceuticals) |
|---|---|
| Exchange | NYSE, US |
| Last close | 11.31 USD (-3.91%) |
| 52-week range | 7.82 USD – 12.76 USD |
| Trend regime | Range |
| 14-day RSI | 74.5 (Overbought) |
| Trailing P/E | -20.64 |
| Market cap | 1.50B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for TRLV
Covered Call on TRLV: how it works, illustrative setup around the real 11.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TRLV: how it works, illustrative setup around the real 11.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TRLV: how it works, illustrative setup around the real 11.31 USD price, max profit/loss, breakeven and when to use it. Educational.
TRLV technical analysis: range, last 11.31 USD, RSI 74.5, 52w range 7.82 USD–12.76 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is TRLV in?
Trulieve Cannabis (TRLV) is classified under Healthcare (Medical - Pharmaceuticals), listed on NYSE, US.
Is TRLV in an uptrend or downtrend?
As of 2026-09-11, TRLV is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TRLV's trailing P/E ratio?
TRLV's trailing P/E is -20.64, with a market cap of 1.50B. See the earnings research page for full valuation detail.
When does TRLV next report earnings?
TRLV is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of 0.08633 USD.